Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

============================================================

Thursday, December 4, 2014

TAKE MS ACTION - LIVE Webcast - December 6th with Madeleine Stowe

  LIVE WEBCAST 
this Saturday - December 6th
See BELOW and register











Aubagio Logo
AUBAGIO® is available in 14 mg and 7 mg tablets.
Trouble viewing? View as a Web page
IMPORTANT SAFETY INFORMATION
Do not take AUBAGIO if you have severe liver problems,
are pregnant or are of childbearing age and not using effective birth control, or are taking a medication called leflunomide.
Please click here for full Prescribing Information,
including boxed WARNING and Medication Guide
genzyme - A SANOFI COMPANY - LIGHTS, CAMERA, TAKE ACTION ON MS - Featuring Madeleine Stowe
Madeleine Stowe is Coming to You Live!
Genzyme has teamed up with TV and film actress Madeleine Stowe to launch “Lights, Camera, Take Action on MS.” This program is aimed at providing education and resources to people living with relapsing forms of multiple sclerosis and their families – so they can take action to help manage the disease.
Event Location: Live Online Webcast
Event Address: Webcast details to be emailed to registrants 5 days prior to event
Event Date: December 6, 2014
Visit TakeActionMS.com to sign up for this live event. Madeleine will share her personal connection to the disease, and you can learn about topics ranging from managing stress and maintaining energy to the emotional impact of MS.
Go to AUBAGIO.com to learn about the impact of AUBAGIO 14 mg on relapse rates, disability progression and lesions on MRI scans.
AUBAGIO® (teriflunomide) is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS).
VISIT TAKEACTIONMS.COM
IMPORTANT SAFETY INFORMATION
Do not take AUBAGIO:
• If you have severe liver problems. AUBAGIO may cause serious liver problems, which can be life-threatening. Your risk may be higher if you take other medicines that affect your liver. Your healthcare provider should do blood tests to check your liver within 6 months before you start AUBAGIO and monthly for 6 months after starting AUBAGIO. Tell your healthcare provider right away if you develop any of these symptoms of liver problems: nausea, vomiting, stomach pain, loss of appetite, tiredness, yellowing of your skin or whites of your eyes, or dark urine.
• If you take a medicine called leflunomide.
• If you are pregnant or are of childbearing potential and not using effective birth control. AUBAGIO may harm an unborn baby. You should have a pregnancy test before starting AUBAGIO. After stopping AUBAGIO, continue to use effective birth control until you have made sure your blood levels of AUBAGIO are lowered. If you become pregnant while taking AUBAGIO or within 2 years after stopping, tell your healthcare provider right away and enroll in the AUBAGIO Pregnancy Registry at 1-800-745- 4447, option 2.
It is not known if AUBAGIO passes into breast milk. Your healthcare provider can help you decide if you should take AUBAGIO or breastfeed – you should not do both at the same time.
If you are a man whose partner plans to become pregnant, you should stop taking AUBAGIO and talk with your healthcare provider about reducing the levels of AUBAGIO in your blood. If your partner does not plan to become pregnant, use effective birth control while taking AUBAGIO.
AUBAGIO may stay in your blood for up to 2 years after you stop taking it. Your healthcare provider can prescribe a medicine that can remove AUBAGIO from your body quickly.
Before taking AUBAGIO, talk with your healthcare provider if you have: liver or kidney problems; a fever or infection, or if you are unable to fight infections; numbness or tingling in your hands or feet that is different from your MS symptoms; diabetes; serious skin problems when taking other medicines; breathing problems; or high blood pressure. Your healthcare provider will check your white blood cell count and TB test before you start AUBAGIO. Talk with your healthcare provider if you take or are planning to take other medicines (especially medicines for treating cancer or controlling your immune system), vaccines, vitamins or herbal supplements.
AUBAGIO may cause serious side effects, including: reduced white blood cell count – this may cause you to have more infections; numbness or tingling in your hands or feet that is different from your MS symptoms; kidney problems; high potassium levels in your blood; serious skin problems; breathing problems (new or worsening); and high blood pressure.
The most common side effects when taking AUBAGIO include: abnormal liver test results; hair thinning or loss; diarrhea; flu; upset stomach; and burning or prickling feeling in your skin. These are not all the side effects of AUBAGIO. Tell your healthcare provider about any side effect that bothers you.
Consult your healthcare provider if you have questions about your health or any medications you may be taking, including AUBAGIO.
You are encouraged to report side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please click here for full Prescribing Information, including boxed WARNING and Medication Guide.

No comments: